3654 results for «370»
3654 results
How should I treat a patient with multivessel disease - A patient's journey
04 Mar 2023 – From AfricaPCR 2023
In this session, study the case of a 55-year-old female patient with DM and previous inferior STEMI, who presented with minimal exertion angina, 48% EF and mild MR, and follow her journey to understand how to optimally handle the specifics of patients with multivessel disease.
Calcified left main bifurcation PCI: how to evaluate and how best to treat - LIVE case
04 Mar 2023 – From AfricaPCR 2023
A 62-year-old male with hormonal treatment (metastatic prostate carcinoma) presents an exertion angina due to an MVD: severe calcified stenoses of distal left main (medina 1-1-1), mid LAD and prox CX.
Watch how the operators prepare LAD and CX lesions with Rotablator (Burrs: 1.25 + 1.75) then...
Calcification clinical cases
04 Mar 2023 – From AfricaPCR 2023
Learn more about transcatheter lithotripsy for aortic subvalvar calcification or LIMA and left anterior descending perforation in this session dedicated to calcification which includes 5 different clinical cases.
How should I treat a patient with bifurcation coronary disease - A patient's journey
04 Mar 2023 – From AfricaPCR 2023
Consider the case of a 66-year-old male patient with no previous cardiac history, but HTN for 20 years, presenting after a successfully thrombolysed inferior STEMI within the 12 hours, no other immediately obvious risk factor for IHD, good baseline functional capacity and normal bio-profile, and compare...
Transcatheter dilatation of aorta coarctation in a 5-month-old baby - LIVE case
04 Mar 2023 – From AfricaPCR 2023
A 5-month-old baby girl with hypoplastic left heart syndrome was born at term (3 Kg) with associated large ASD secundum. A surgical repaired aortic arch with ASD and PDA closing was performed at 2 weeks old. At 5 months, she presented a re-coarctation of the aorta (65...
How should I treat a patient with STEMI - A patient's journey
04 Mar 2023 – From AfricaPCR 2023
The case presented in this session is that of a 39-year-old mother and housewife, diabetic for 5 years, who was transferred to the hub for primary PCI and found to have an acute inferior STEMI: follow her journey and the discussions around her treatment management.
Intervention makes a difference
04 Mar 2023 – From AfricaPCR 2023
This AfricaPCR 2023 session includes presentations of 5 cases highlighting the importance of percutaneous interventions, which often have a considerable impact on the patients who undergo them.
Coronary clinical cases - session 3
04 Mar 2023 – From AfricaPCR 2023
Among the 6 presentations offered in this AfricaPCR 2023 session, find out more about a multivessel PCI and tight aortic stenosis, the case of a 6-year-old boy with HTN and dilated cardiomyopathy, a hybrid SVG calcium modification, and rare complications in a TAVI case.
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis
07 Nov 2021
Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.
Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
Transfemoral TAVI in the horizontal aorta
12 May 2020
Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.
